Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.31 USD | +2.89% | -0.63% | +32.24% |
13/05 | Piper Sandler Adjusts Price Target on Myriad Genetics to $28 From $23, Maintains Neutral Rating | MT |
08/05 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.24% | 228.89Cr | |
-4.42% | 1.23TCr | |
-5.19% | 806.62Cr | |
+8.59% | 591.18Cr | |
+28.50% | 552.21Cr | |
-8.09% | 421.2Cr | |
+13.49% | 273.28Cr | |
-1.64% | 242.91Cr | |
-3.55% | 188.74Cr | |
+3.02% | 159.94Cr |
- Stock Market
- Equities
- MYGN Stock
- News Myriad Genetics, Inc.
- Myriad Genetics Names Sam Raha as Chief Operating Officer